Table 3.
Univariate analysis of inflammatory biomarkers and restenosis risk and mortality.
| Restenosis | Mortality | |
|---|---|---|
| Low-MLR vs. high-MLR | 15/225 (6.67%) vs. 60/144 (41.67%) p < 0.0001 |
10/237 (4.22%) vs. 28/132 (21.21%) p < 0.0001 |
| Low-NLR vs. high-NLR | 7/236 (2.97%) vs. 68/133 (51.13%) p < 0.0001 |
4/274 (1.46%) vs. 34/95 (57.36%) p < 0.0001 |
| Low-PLR vs. high-PLR | 21/255 (8.24%) vs. 54/114 (47.37%) p < 0.0001 |
8/265 (3.02%) vs. 30/104 (28.85%) p < 0.0001 |
| Low-SII vs. high-SII | 14/251 (5.58%) vs. 61/118 (51.69%) p < 0.0001 |
5/258 (1.94%) vs. 33/111 (29.73%) p < 0.0001 |
| Low-SIRI vs. high-SIRI | 14/247 (5.67%) vs. 61/122 (50%) p < 0.0001 |
8/248 (3.23%) vs. 30/121 (24.79%) p < 0.0001 |
| Low-AISI vs. high-AISI | 13/242 (5.37%) vs. 62/127 (48.82%) p < 0.0001 |
9/247 (3.64%) vs. 29/122 (23.77%) p < 0.0001 |
MLR = monocyte-to-lymphocyte ratio; NLR = neutrophil-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio; SII = systemic inflammatory index; SIRI = systemic inflammation response index; AISI = aggregate index of systemic inflammation.